Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Naloxone for Post Spinal Fusion Ileus
NCT03176316Phase 4Terminated
- Sponsor
- Loyola University Chicago
- Start
- Sep 2017
- Primary completion
- Feb 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of naloxone in postoperative ileus (POI), sponsored by Loyola University Chicago. Started Sep 2017; status: terminated.
02
Drugs
naloxone
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT03176316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03176316.